Avalon Globocare (OTCMKTS:AVCO) Trading 7.4% Higher

Avalon Globocare Corp (OTCMKTS:AVCO)’s stock price traded up 7.4% during trading on Monday . The company traded as high as $2.50 and last traded at $2.47, 106,334 shares were traded during mid-day trading. A decline of 70% from the average session volume of 359,500 shares. The stock had previously closed at $2.30.

The stock’s fifty day moving average price is $1.98 and its 200 day moving average price is $2.87.

Large investors have recently modified their holdings of the company. BlackRock Inc. bought a new position in shares of Avalon Globocare during the 2nd quarter valued at $2,535,000. Vanguard Group Inc. grew its holdings in shares of Avalon Globocare by 27.2% during the 2nd quarter. Vanguard Group Inc. now owns 714,159 shares of the company’s stock valued at $1,857,000 after purchasing an additional 152,648 shares during the last quarter. Anson Funds Management LP bought a new position in shares of Avalon Globocare during the 2nd quarter valued at $307,000. Charles Schwab Investment Management Inc. bought a new position in shares of Avalon Globocare during the 2nd quarter valued at $117,000. Finally, Bank of New York Mellon Corp bought a new position in shares of Avalon Globocare during the 2nd quarter valued at $88,000.



About Avalon Globocare (OTCMKTS:AVCO)

Avalon GloboCare Corp., together with its subsidiaries, engages in integrating and managing healthcare services and resources in the United States. It provides medical related consulting services and develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology.

Featured Article: How Do Investors Open a Backdoor Roth IRA?

Receive News & Ratings for Avalon Globocare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon Globocare and related companies with MarketBeat.com's FREE daily email newsletter.